consideration objectives: To determine if an educational intervention targeting urgency department (ED) and medicine staff could prosperously decrease the time to antibiotic delivery (door-to-drug delivery time [DDD]) for patients admitted end the ED with community-acquired pneumonia (CAP).

Design: Prospective, multidisciplinary team-based educational contrive Demographics, outcomes, and processes of care including DDD and sputum management for patients with CAP were determined during a baseline period and compared to the same parameters for patients with CAP presenting after the educational intervention was administered to ed and medicine staff.

Setting: Barnes-Jewish Hospital, a large Midwest teaching institution affiliated with the Washington University exercise of Medicine.

Patients: Consecutive adult patients admitted in consequence of the ED with CAP.

Intervention: Multidisciplinary in-service education administered to ed physicians and nurses, and medicine housestaff, which emphasized the importance of rapid antibiotic delivery and management of preantibiotic expectorated sputum.

Results: Mean DDD improved from 413 to 291 min (p = 002) with more patients receiving antibiotics in the ed (46% vs 69%; adjusted left over s ratio [OR], 2.3; 95% confidence interval [CI], 10 to 49) Sputum contrivance improved from 11.5 to 254% (adjusted OR, 33; 95% CI, 11 to 99) There were no observ differences for inpatient mortality or duration of stay.

Conclusion: This multidisciplinary team intervention significantly improved the time to initiation of antibiotics and management of sputum for patients with CAP.

guide words: antibiotic; community-acquired pneumonia; medicine delivery; quality improvement; sputum

Abbreviations: ATS = American Thoracic Society; CAP = community-acquired pneumonia; CI = confidence interval; DDD = door-to-drug delivery time; ed = emergency department; IDSA = Infectious Diseases Society of America; looks = length of stay; OR = not divisible by 2s ratio; PSI = pneumonia severity of illness index

**********

Community-acquired pneumonia (CAP) affects 2 to 3 million commonalty annually, causing approximately 45,000 deaths, making it the leading infectious cause of mortality in the United States. (1-3) Larger studies have estimated mortality for hospitalized patients with CAP at 7 to 14% (4-6) and median duration of stay (LOS) from 5 to 8 days, with a high standing of interhospital variability. (4,7,8) Many efforts have been made in newly come years to identify and improve processe of care for patients with CAP. Those that have been mostly frequently identified include the time elapsed prior to initiation of antibiotic therapy (the door-to-drug delivery time [DDD]) and performance of preantibiotic kindred cultures and expectorated sputum Gram stain and agriculture (9-12)

Meehan and colleagues (9) demonstrated an important link between a DDD of < 8 h and 30-day mortality in an somewhat advanced in life CAP population. Subsequently, there have been small in number reported quality improvement projects describing interventions to improve the DDD Metersky and colleagues (10) reported a statistically significant aggregate DDD reduction from 55 to 47 h in four of six participating hospitals that implemented separate, nonstandardized interventions. The improvement was attributed to an increase in the receipt of first dose of antibiotic within 4 h and in the exigency department (ED). (10) McGarvey and Harper (12) initiated a clinical pathway that l to a higher proportion of patients receiving antibiotics within 4 h (from 42 to 87%); however, statistical significance was not reported. Other collections have also recognized the importance of antibiotic receipt within 4 h (13)

In their respective consensus guidelines for the management of CAP, the Infectious Diseases Society of America (IDSA) advocates routine preantibiotic expectorated sputum agency and analysis by Gram stain and tillage (14,15) while the American Thoracic Society (ATS) approves performance of these diagnostic studies and nothing else if resistant pathogens are suspected. (16) The discussion over routine sputum analysis is longstanding because of the many factors that limit its diagnostic utility, (17-21) the wide range of reported sensitivities and specificities (35 to 96% and 12 to 96% respectively), (1722-28) and the lack of controll studies to indicate that sputum analysis improves issues for patients with CAP. Nonetheless, the rationale for the IDSA recommendation was that sputum analysis is an inexpensive touchstone that, if done correctly, can guide antibiotic selection to better treat resistant organisms, avoid exces sumptuousness and adverse effects associated with broader image antibiotics, and reduce the spread of antibiotic resistance. (1415) Indeed, a prospective meditation (28) confirmed that although sensitivity is not high, positive sputum analysis findings can help guide therapy. In this setting of conflicting recommendations, routine sputum analysis for CAP patients is not standard practice in near institutions. (29) The purpose of this cogitation was to improve time to initiation of antibiotics and procuration of preantibiotic expectorated sputum from patients presenting to the ed with CAP, in accordance with guideline recommendations.

...